A detailed history of Cypress Capital Advisors, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Cypress Capital Advisors, LLC holds 5,550 shares of TWST stock, worth $167,277. This represents 0.13% of its overall portfolio holdings.

Number of Shares
5,550
Previous 5,577 0.48%
Holding current value
$167,277
Previous $219 Million 6.74%
% of portfolio
0.13%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 27, 2025

SELL
$28.16 - $40.27 $760 - $1,087
-27 Reduced 0.48%
5,550 $204 Million
Q4 2024

Aug 27, 2025

BUY
$36.89 - $52.7 $205,735 - $293,907
5,577 New
5,577 $259 Million

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $1.7B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Cypress Capital Advisors, LLC Portfolio

Follow Cypress Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Advisors, LLC with notifications on news.